Logo image of FPN.PA

FONCIERE PARIS NORD (FPN.PA) Stock Fundamental Analysis

Europe - EPA:FPN - FR0011277391 - Common Stock

0.0272
+0 (+3.82%)
Last: 4/27/2022, 7:00:00 PM
Fundamental Rating

1

Overall FPN gets a fundamental rating of 1 out of 10. We evaluated FPN against 40 industry peers in the Diversified REITs industry. FPN may be in some trouble as it scores bad on both profitability and health. FPN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FPN had negative earnings in the past year.
FPN.PA Yearly Net Income VS EBIT VS OCF VS FCFFPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 0 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -18.97%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FPN.PA Yearly ROA, ROE, ROICFPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 0 500 -500 -1K

1.3 Margins

Industry RankSector Rank
OM -1332.91%
PM (TTM) -1552.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FPN.PA Yearly Profit, Operating, Gross MarginsFPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 0 -500 -1K -1.5K

More info and screens

1

2. Health

2.1 Basic Checks

FPN has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for FPN has been reduced compared to a year ago.
FPN.PA Yearly Shares OutstandingFPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 20M 40M 60M 80M
FPN.PA Yearly Total Debt VS Total AssetsFPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -3.19, we must say that FPN is in the distress zone and has some risk of bankruptcy.
FPN has a Debt/Equity ratio of -0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Altman-Z -3.19
ROIC/WACCN/A
WACCN/A
FPN.PA Yearly LT Debt VS Equity VS FCFFPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 0 2M -2M -4M -6M -8M

2.3 Liquidity

FPN has a Current Ratio of 0.03. This is a bad value and indicates that FPN is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.03 indicates that FPN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
FPN.PA Yearly Current Assets VS Current LiabilitesFPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.08% over the past year.
Looking at the last year, FPN shows a very negative growth in Revenue. The Revenue has decreased by -20.95% in the last year.
The Revenue for FPN have been decreasing by -34.50% on average. This is quite bad
EPS 1Y (TTM)5.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.56%
Revenue 1Y (TTM)-20.95%
Revenue growth 3Y-41.21%
Revenue growth 5Y-34.5%
Sales Q2Q%-4.55%

3.2 Future

Based on estimates for the next years, FPN will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.10% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-20%
EPS Next 2Y41.42%
EPS Next 3Y11.87%
EPS Next 5Y18.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FPN.PA Yearly Revenue VS EstimatesFPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 500K 1M 1.5M
FPN.PA Yearly EPS VS EstimatesFPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2022 2023 2024 2025 -0 -0 -0.01 -0.01

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FPN.PA Price Earnings VS Forward Price EarningsFPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FPN.PA Per share dataFPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y11.87%

More info and screens

0

5. Dividend

5.1 Amount

FPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FONCIERE PARIS NORD

EPA:FPN (4/27/2022, 7:00:00 PM)

0.0272

+0 (+3.82%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.15M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.15
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS-0.13
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1332.91%
PM (TTM) -1552.14%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -3.19
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.56%
EPS Next Y-20%
EPS Next 2Y41.42%
EPS Next 3Y11.87%
EPS Next 5Y18.1%
Revenue 1Y (TTM)-20.95%
Revenue growth 3Y-41.21%
Revenue growth 5Y-34.5%
Sales Q2Q%-4.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A